Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Oonagh Sheehy"'
Autor:
Nini Aung, Margaret Bowers, Gillian Brearton, Andrew Charlton, Joanne Craig, Jonathan Cullis, Ray Dang, David Donaldson, Mary Drake, Rachel Hall, Elizabeth Parkins, Jane Tighe, Ceri Bygrave, Oonagh Sheehy
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 987-991 (2024)
Abstract This report describes the characteristics and outcomes of 18 heavily pretreated patients with multiple myeloma (MM) who were subsequently treated with selinexor. This is a case series of 18 patients with MM who were treated with selinexor an
Externí odkaz:
https://doaj.org/article/456cfae128ad4e339dda45d427858acc
Autor:
Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collins, Javier L. Jiménez, Mark Bishton, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendraprasad Sungala, Gerardo Musuraca, Oonagh Sheehy, Eric Van Den Neste, Mitsuhiko Odera, Lu Miao, Daniel P. Gold, Richard G. Ghalie, Pier L. Zinzani
Publikováno v:
HemaSphere, Vol 8, Iss 8, Pp n/a-n/a (2024)
Abstract In this global phase 2 study in patients with relapsed/refractory follicular lymphoma (FL), zandelisib was administered on intermittent dosing to mitigate immune‐related adverse events and infections that have been reported with oral PI3K
Externí odkaz:
https://doaj.org/article/01ca8e0063d3415eb0c1d640ff74ac54
Autor:
Panagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, Aliki Xochelli, Sabine Jeromin, Andreas Agathangelidis, Mattias Mattsson, Lesley-Ann Sutton, Eva Minga, Lydia Scarfò, Davide Rossi, Zadie Davis, Neus Villamor, Helen Parker, Jana Kotaskova, Evangelia Stalika, Karla Plevova, Larry Mansouri, Diego Cortese, Alba Navarro, Julio Delgado, Marta Larrayoz, Emma Young, Achilles Anagnostopoulos, Karin E. Smedby, Gunnar Juliusson, Oonagh Sheehy, Mark Catherwood, Jonathan C. Strefford, Niki Stavroyianni, Chrysoula Belessi, Sarka Pospisilova, David Oscier, Gianluca Gaidano, Elias Campo, Claudia Haferlach, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Chronic lymphocytic leukemia (CLL) patients with differential somatic hypermutation status of the immunoglobulin heavy variable genes, namely mutated or unmutated, display fundamental clinico-biological differences. Considering this, we assessed prog
Externí odkaz:
https://doaj.org/article/52a899077fd1453f94e9b19946a4d882
Autor:
Andrew D. Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim M. Linton, Graham P. Collins, Mark Bishton, Javier López Jiménez, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J. Phillips, Nagendra Prasad Sungala, Henry Chan, Gerardo Musuraca, Oonagh Sheehy, Junyi Yan, Weiming Xu, Michel Azoulay, Pier Luigi Zinzani
Publikováno v:
Blood. 140:3595-3597
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c4a633e7275417b2128f14b39f30db9
https://doi.org/10.1182/blood-2022-165409
https://doi.org/10.1182/blood-2022-165409
Autor:
Talha Munir, Alexandra Pitchford, Adrian Bloor, Andrew Pettitt, Piers E.M. Patten, Francesco Forconi, Anna Schuh, Christopher P Fox, Simona Gatto, Ben Kennedy, John Gribben, Nicholas Pemberton, Oonagh Sheehy, Gavin Preston, Dena Howard, Anna Hockaday, David Cairns, Sharon Jackson, Natasha Greatorex, Nichola McWhirter, Jane Shingles, Kate Cwynarski, Shankara Paneesha, David Allsup, Andrew Rawstron, Peter Hillmen
Publikováno v:
Blood. 140:231-233
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7fe85f55e9f896e126a489cbfa6db36
https://doi.org/10.1182/blood-2022-170463
https://doi.org/10.1182/blood-2022-170463
Autor:
Antonia S Carroll, Carolynne M Doherty, Julian Blake, Stephen J Hunt, Chandrashekar Hoskote, Feargal McNicholl, Rahul Phadke, Oonagh Sheehy, Fion D Bremner, Shirley D'Sa, Christopher McNamara, Mary M Reilly
Publikováno v:
Practical Neurology. 22:396-406
The histiocytoses are a group of rare disorders characterised by the accumulation of neoplastic or non-neoplastic activated histiocytes in various tissues. Phenotypes vary widely from cutaneous lesions or lymphadenopathy that regress spontaneously to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71561462116109d4c075bf399450069a
https://doi.org/10.1136/practneurol-2022-003398
https://doi.org/10.1136/practneurol-2022-003398
Autor:
Tycel Phillips, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collin, Javier Lopéz-Jimenéz, Nishitha Reddy, Andrea Mengarelli, Gerardo Musuraca, Oonagh Sheehy, Weiming Xu, Michel Azoulay, Richard G. Ghalie, Pier Luigi Zinzani, Andrew D. Zelenetz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S387-S388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73775f862a6d57a830210ef1c0030a5d
https://doi.org/10.1016/s2152-2650(22)01555-5
https://doi.org/10.1016/s2152-2650(22)01555-5
Autor:
Adam, Henry, Ailish, Nugent, Ian R, Wallace, Bode, Oladipo, Oonagh, Sheehy, Philip C, Johnston
Publikováno v:
The Ulster Medical Journal
The pituitary gland is an unusual site for metastatic spread and has been associated with a poor prognosis. Clinical presentation is variable but can include visual field defects, cranial nerve palsies, anterior pituitary dysfunction and/ or diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8d557b64a04bed67a1b0a0ba1b53c92
https://pubmed.ncbi.nlm.nih.gov/34815592
https://pubmed.ncbi.nlm.nih.gov/34815592
Autor:
Tycel Phillips, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collin, Javier Lopéz-Jimenéz, Nishitha Reddy, Andrea Mengarelli, Gerardo Musuraca, Oonagh Sheehy, Weiming Xu, Michel Azoulay, Richard G. Ghalie, Pier Luigi Zinzani, Andrew D. Zelenetz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::930a99be6941b650d064309c82d592c9
https://doi.org/10.1016/s2152-2650(22)01063-1
https://doi.org/10.1016/s2152-2650(22)01063-1
Autor:
Andrew David Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P. Collins, Javier López-Jiménez, Nishitha Reddy, Andrea Mengarelli, Tycel Jovelle Phillips, Gerardo Musuraca, Oonagh Sheehy, Joanne Li, Weiming Xu, Michel Meyer Azoulay, Richard Ghalie, Pier Luigi Zinzani
Publikováno v:
Journal of Clinical Oncology. 40:7511-7511
7511 Background: Zandelisib, a PI3Kδ inhibitor with high target-binding affinity, is administered by intermittent dosing (ID) on days 1-7 of 28-day cycles to potentially enable regulatory T-cell repopulation and lower the risk of immune adverse even
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77495d72f514a67d5d91f53708dbd45a
https://doi.org/10.1200/jco.2022.40.16_suppl.7511
https://doi.org/10.1200/jco.2022.40.16_suppl.7511